What Apple Said

News

Upgrades

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

AAPL

BBWI

SBUX

SIRI

This Apple Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday

analyst ratings image

Deep Dive Into Mastercard Stock: Analyst Perspectives (17 Ratings)

ABSI

Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

HCAT

Forecasting The Future: 10 Analyst Projections For Health Catalyst

SI-BONE (NASDAQ:SIBN) Bolsa, Calificaciones de analistas, precios objetivo, pronóstico

SI-BONE INC

SI-BONE

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Movers

AEON

ANIP

BBAI

BLRX

CFFI

DOYU

GCTK

LUXH

PMAX

QUBT

RIME

SANG

SIBN

SLXN

SOBR

SONM

TNXP

WHLR

TSMC y otras acciones destacaron en el premercado tras reportar ganancias récord. Descubre los mayores ganadores y perdedores.

Acciones de Taiwan Semiconductor (TSM) suben alrededor del 5%; 20 acciones en movimiento en el premercado de EE.UU.

SI-BONE Inc

Press Releases

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

General

SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation

SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024

Health Care

SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™

Earnings

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance

SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024

SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025

Bruker Appoints Laura Francis to its Board of Directors

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance

BRKR

PGNY

SWAV

AngioDynamics

Artivion

Alphatec Holdings

AtriCure

Axogen

Beta Bionics

Butterfly Network, Inc. Class A Common Stock

Butterfly Network

CeriBell

ClearPoint Neuro

Delcath Systems

Paragon 28

Integra LifeSciences Holdings Corporation - Common Stock

Integra Lifesciences

iRadimed

Kestra Medical Technologies, Ltd. - Common Stock

Kestra Medical Techs

NeuroPace

Orthofix Medical

Omnicell

Pulse Biosciences

Senseonics Holdings

Semler Scientific

Surmodics

Tactile Systems Technology, Inc. - Common Stock

Tactile Systems Tech

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts

Tandem Diabetes Care, Inc. - Common Stock

Tandem Diabetes Care

Varex Imaging

Citizens Capital Markets

Truist Securities

Cantor Fitzgerald

Needham

Morgan Stanley

Application error: a client-side exception has occurred (see the browser console for more information).